Pomerantz LLP Announces Class Action Litigation Filing Against Inovio Pharmaceuticals, Inc. – INO
NEW YORK CITY, NY / ACCESS Newswire / February 6, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ:INO) and certain officers.â?¯â?¯ The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 26-cv-00803, […]